Fuder H, Schwarz P
Pharmakologisches Institut, Universität Mainz, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Aug;348(2):127-33. doi: 10.1007/BF00164788.
To find out whether sympathetic nerves of the rabbit heart possess pharmacologically relevant prejunctional imidazoline receptors different from alpha-autoreceptors, the inhibition by oxymetazoline, aganodine and BDF 6143 (4-chloro-2-[2-imidazoline-2-ylamino]-isoindoline hydrochloride) of endogenous noradrenaline overflow evoked by stimulation of extrinsic postganglionic sympathetic nerves (0.66 Hz, 80 pulses) was investigated. In addition we wanted to find out whether either type of these prejunctional receptors undergoes desensitization upon pre-exposure to respective agonists. The alpha 2-adrenoceptor agonist oxymetazoline inhibited the evoked noradrenaline overflow (2.9 nmol/l, IC50; about 90%, maximum inhibition). The inhibition was antagonized by rauwolscine (-log KB 8.20). This confirms the presence of alpha 2-autoreceptors. Endogenous noradrenaline activated autoinhibition to a small extent as indicated by a rauwolscine-induced increase in evoked overflow by less than 2-fold. The alpha 2- and imidazoline receptor agonist aganodine inhibited the evoked noradrenaline overflow (2.4 nmol/l, IC50; about 80%, maximum inhibition). The inhibition was antagonized by rauwolscine with a potency (-log KB 6.75), about 1/30 of that found at the alpha 2-autoreceptor. Neither an alpha 2-selective low concentration of rauwolscine nor the alpha 1-adrenoceptor antagonist prazosin, nor SKF 104078, a mixed alpha 1/2-antagonist, reduced the aganodine effect. The alpha 2-adrenoceptor antagonist and imidazoline receptor agonist BDF 6143 inhibited the evoked noradrenaline overflow (18 nmol/l, IC50; about 70% maximum inhibition). The inhibition was insensitive to a low rauwolscine concentration.(ABSTRACT TRUNCATED AT 250 WORDS)
为了探究兔心脏的交感神经是否具有与α-自身受体不同的、药理学上相关的节前咪唑啉受体,研究了羟甲唑啉、阿加诺定和BDF 6143(4-氯-2-[2-咪唑啉-2-基氨基]-异吲哚啉盐酸盐)对刺激节后交感神经(0.66 Hz,80个脉冲)诱发的内源性去甲肾上腺素溢出的抑制作用。此外,我们还想了解这些节前受体中的任何一种在预先暴露于各自的激动剂后是否会发生脱敏。α2-肾上腺素能受体激动剂羟甲唑啉抑制诱发的去甲肾上腺素溢出(2.9 nmol/l,IC50;约90%,最大抑制)。这种抑制作用被萝芙辛拮抗(-log KB 8.20)。这证实了α2-自身受体的存在。如萝芙辛诱导的诱发溢出增加不到2倍所示,内源性去甲肾上腺素在小程度上激活了自身抑制。α2-和咪唑啉受体激动剂阿加诺定抑制诱发的去甲肾上腺素溢出(2.4 nmol/l,IC50;约80%,最大抑制)。这种抑制作用被萝芙辛拮抗,其效力(-log KB 6.75)约为在α2-自身受体处发现的1/30。低浓度的α2-选择性萝芙辛、α1-肾上腺素能受体拮抗剂哌唑嗪以及α1/2-混合拮抗剂SKF 104078均未降低阿加诺定的作用。α2-肾上腺素能受体拮抗剂和咪唑啉受体激动剂BDF 6143抑制诱发的去甲肾上腺素溢出(18 nmol/l,IC50;约70%最大抑制)。这种抑制作用对低浓度的萝芙辛不敏感。(摘要截断于250字)